secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alaunos Therapeutics, Inc. (TCRT)
CIK:        0001107421
Form:       8-K
Filed at:   2023-09-28T23:59:59+00:00
Accession:  0001193125-23-245602
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Alaunos Therapeutics Chairman James Huang resigns; Holger Weis elected successor
--------------------------------------------------------------------------------

- James Huang resigned as Chairman and board member effective September 22, 2023.
- Resignation not due to any disagreement on operations, policies, or practices.
- Board elected Holger Weis as new Chairman of the Board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1107421/000119312523245602/0001193125-23-245602-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1107421/000119312523245602/d469943d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-245602

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer